Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
Top Cited Papers
- 25 March 2014
- Vol. 100 (Suppl 2), ii1-ii67
- https://doi.org/10.1136/heartjnl-2014-305693
Abstract
This is the 3rd iteration of the Joint British Societies ( JBS) recommendations for the prevention of cardiovascular disease. Current prevention strategies tend to focus upon patients at relatively short term (10-year) risks and upon specific thresholds for pharmacologic therapies, although there is considerable variability among the different guidelines. This approach is logical and has been successful in directing therapy to those at highest risk who stand to gain the greatest benefit.Keywords
This publication has 98 references indexed in Scilit:
- Usefulness of Risk Scores to Estimate the Risk of Cardiovascular Disease in Patients With Rheumatoid ArthritisThe American Journal of Cardiology, 2012
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular DiseaseThe American Journal of Cardiology, 2011
- Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery DiseaseJAMA, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Vitamins E and C in the Prevention of Cardiovascular Disease in MenJAMA, 2008
- Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and MortalityJAMA, 2008
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in WomenArchives of Internal Medicine, 2007
- Longitudinal Follow-up and Outcomes Among a Population With Chronic Kidney Disease in a Large Managed Care OrganizationArchives of Internal Medicine, 2004